- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04965103
Superior Capsule vs Bridging Study (SCR)
July 6, 2021 updated by: University of Calgary
Graft Reconstruction for Irreparable Rotator Cuff Tears: Superior Capsule Reconstruction or Tendon Repair With Graft Interposition
Randomized controlled trial examining superior capsule reconstruction versus tendon repair with graft interposition in "irreparable" rotator cuff tears.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
RCT n = 50
Groups:
- bridging
- SCR
Outcomes:
- WORC
- ASES
- QuickDASH
- MRI at 12 months post-op
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Large to massive rotator cuff tear (with or without subscapularis tear) that may possibly be irreparable without the use of graft materials (confirmed intra-operatively)
- Either primary tear or re-tear after previous repair
- Radiographic evidence of Hamada stage 1-3, with or without Samilson & Prieto mild osteoarthritis (<3mm inferior osteophyte)
Exclusion Criteria:
- Primary glenohumeral osteoarthritis: radiographic evidence of Samilson & Prieto classification moderate or greater
- Cuff tear arthropathy (CTA): radiographic evidence of Hamada stage 4 or above
- Inflammatory joint disease of the shoulder (e.g. rheumatoid arthritis)
- Medical issues precluding surgery
- Unwilling or unable to complete study outcomes
- Worker's Compensation Claim or litigation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Bridging
Tendon repair with graft interposition
|
Tendon repair with graft interposition
|
|
Experimental: SCR
Superior Capsule reconstruction
|
Superior Capsule reconstruction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
American Shoulder and Elbow Surgeon Outcome - patient portion
Time Frame: 24 months
|
American Shoulder and Elbow Surgeon Outcome - patient portion (minimum score = 0, maximum score = 100, best outcome = 100)
|
24 months
|
|
American Shoulder and Elbow Surgeon Outcome - patient portion
Time Frame: 12 months
|
American Shoulder and Elbow Surgeon Outcome - patient portion (minimum score = 0, maximum score = 100, best outcome = 100)
|
12 months
|
|
American Shoulder and Elbow Surgeon Outcome - patient portion
Time Frame: 6 months
|
American Shoulder and Elbow Surgeon Outcome - patient portion (minimum score = 0, maximum score = 100, best outcome = 100)
|
6 months
|
|
American Shoulder and Elbow Surgeon Outcome - patient portion
Time Frame: 3 months
|
American Shoulder and Elbow Surgeon Outcome - patient portion (minimum score = 0, maximum score = 100, best outcome = 100)
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Western Ontario Rotator Cuff Index
Time Frame: 24 months
|
Western Ontario Rotator Cuff Index (score converted to /100, minimum = 0, maximum = 100, best outcome = 100)
|
24 months
|
|
Western Ontario Rotator Cuff Index
Time Frame: 12 months
|
Western Ontario Rotator Cuff Index (score converted to /100, minimum = 0, maximum = 100, best outcome = 100)
|
12 months
|
|
Western Ontario Rotator Cuff Index
Time Frame: 6 months
|
Western Ontario Rotator Cuff Index (score converted to /100, minimum = 0, maximum = 100, best outcome = 100)
|
6 months
|
|
Western Ontario Rotator Cuff Index
Time Frame: 3 months
|
Western Ontario Rotator Cuff Index (score converted to /100, minimum = 0, maximum = 100, best outcome = 100)
|
3 months
|
|
Disabilities of the Arm, Shoulder and Hand - QuickDASH
Time Frame: 24 months
|
Disabilities of the Arm, Shoulder and Hand - QuickDASH (minimum = 100, maximum = 0, best outcome = 0)
|
24 months
|
|
Disabilities of the Arm, Shoulder and Hand - QuickDASH
Time Frame: 12 months
|
Disabilities of the Arm, Shoulder and Hand - QuickDASH (minimum = 100, maximum = 0, best outcome = 0)
|
12 months
|
|
Disabilities of the Arm, Shoulder and Hand - QuickDASH
Time Frame: 6 months
|
Disabilities of the Arm, Shoulder and Hand - QuickDASH (minimum = 100, maximum = 0, best outcome = 0)
|
6 months
|
|
Disabilities of the Arm, Shoulder and Hand - QuickDASH
Time Frame: 3 months
|
Disabilities of the Arm, Shoulder and Hand - QuickDASH (minimum = 100, maximum = 0, best outcome = 0)
|
3 months
|
|
Tendon healing, assessed via MRI
Time Frame: 12 months
|
Tendon healing (classifications: intact or retorn)
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ian Lo, MD, University of Calgary
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2016
Primary Completion (Actual)
November 7, 2020
Study Completion (Actual)
December 31, 2020
Study Registration Dates
First Submitted
June 21, 2021
First Submitted That Met QC Criteria
July 6, 2021
First Posted (Actual)
July 16, 2021
Study Record Updates
Last Update Posted (Actual)
July 16, 2021
Last Update Submitted That Met QC Criteria
July 6, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REB15-1787
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No plan to share individual participant data.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.